Comparison
22q11 2 Deletion Syndrome Cn294181 vs 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
Clinical comparison between 22q11 2 Deletion Syndrome CN294181 and 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete CN042980 for differential diagnosis and treatment planning.
22q11 2 Deletion Syndrome Cn294181
A genetic condition where a small piece of chromosome 22 is missing. It can affect the heart, immune system, and development. Treatment involves managing symptoms across multiple specialties.
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
A rare enzyme deficiency affecting hormone production, leading to low sex hormones and elevated blood pressure. Lifelong hormone replacement therapy is typically needed. Ongoing medical monitoring helps manage associated health concerns.
6 comparison axes
Onset
22q11 2 Deletion Syndrome Cn294181
0-null
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
0-null
Onset patterns differ
Severity
22q11 2 Deletion Syndrome Cn294181
severe
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
severe
Different severity levels
Chronic
22q11 2 Deletion Syndrome Cn294181
Chronic
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
Chronic
Differing course
Communicable
22q11 2 Deletion Syndrome Cn294181
No
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
No
Different transmission
Body System
22q11 2 Deletion Syndrome Cn294181
congenital
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
endocrine
Same/different system
Category
22q11 2 Deletion Syndrome Cn294181
genetic
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
endocrine
Different category
Bottom line
22q11-2-deletion-syndrome-CN294181 and 17-alpha-hydroxylase-17-20-lyase-deficiency-combined-complete-CN042980 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 22q11 2 Deletion Syndrome Cn294181 | 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980 | Discriminating power |
|---|---|---|---|
| Core clinical pattern | Variable congenital effects may involve heart, palate, immunity, calcium balance, learning, or development. | Disordered steroid production may cause sex-hormone deficiency and blood-pressure elevation. | High |
| Blood pressure and potassium | Hypertension or low potassium is not a defining feature in the supplied description. | Elevated blood pressure is characteristic; potassium abnormalities may occur but need laboratory confirmation. | High |
| Puberty and sex development | Sex development is not the primary problem described, although associated findings can vary. | Low sex hormones may delay or alter puberty; exact anatomy depends on individual evaluation. | Moderate |
When to favor each condition
Choose 22q11 2 Deletion Syndrome Cn294181 when
Congenital heart, palate, immune, or developmental concerns cluster together
This pattern fits a chromosomal deletion better than an isolated steroid-enzyme defect.
High
A clinician suspects 22q11.2 deletion from dysmorphic or multisystem findings
Targeted genetic testing can establish the deletion; clinical suspicion alone is insufficient.
High
Low calcium or recurrent infections accompany congenital anomalies
These supportive clues warrant genetics and immunology assessment, not a diagnosis by themselves.
Moderate
Choose 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980 when
Hypertension occurs with delayed puberty or sex-hormone deficiency
The combination points toward disordered adrenal and gonadal steroid synthesis.
High
Steroid testing suggests impaired 17-hydroxylation and 17,20-lyase activity
A compatible hormone pattern supports specialist confirmation and genetic testing.
Moderate
A person with either chromosomal sex has absent or incomplete puberty
Sex-steroid deficiency is central, but the exact presentation must be interpreted individually.
Moderate
How key tests differ
| Test | 22q11 2 Deletion Syndrome Cn294181 | 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980 | Interpretation |
|---|---|---|---|
| Genetic testing | May show a deletion at chromosome 22q11.2. | May show causative CYP17A1 variants; a 22q11.2 deletion is not expected. | A confirmed genetic result supports the relevant diagnosis, while a negative result needs specialist review. |
| Steroid and electrolyte panel | No specific steroid pattern is established by the supplied data. | May show low cortisol and sex steroids with mineralocorticoid-precursor excess; cutoffs are not specified here. | Abnormal hormones suggest the enzyme deficiency but require endocrine confirmation. |
| Cardiac and immune evaluation | Echocardiography or lymphocyte studies may reveal clinically important abnormalities. | These tests are not diagnostic; blood-pressure assessment is more relevant. | Abnormal findings guide care but do not independently prove either condition. |
Prognosis comparison
22q11 2 Deletion Syndrome Cn294181
- Outcome
- Lifelong course with highly variable severity; no mortality estimate is established here.
- Factors
- Heart disease, immune function, calcium balance, development, and access to coordinated care.
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
- Outcome
- Chronic endocrine condition that generally requires lifelong hormone management and monitoring.
- Factors
- Blood pressure, electrolytes, cortisol replacement, puberty management, and treatment adherence.
Time frame: Both are chronic, often beginning early, but exact onset is not established by the supplied data.
Prognosis is individualized; these descriptions do not predict survival or complications.
Complications comparison
| Complication | Presentation |
|---|---|
| Cardiovascular complications | Congenital heart disease may require coordinated specialist care. Long-standing hypertension may cause cardiovascular harm if inadequately controlled. The mechanisms differ, and individual risk is not established here. |
| Hormone or mineral imbalance | Low calcium and related neuromuscular symptoms may occur. Cortisol deficiency and potassium or blood-pressure imbalance may require urgent care. Neither complication is universal; monitoring should be individualized. |
| Development and reproductive health | Learning, speech, behavioral, or psychiatric difficulties may occur. Pubertal disruption and reduced fertility are potential concerns. Outcomes vary and should not be predicted from the diagnosis alone. |
Patient education highlights
- HighDifferent causes
One condition results from missing chromosomal material; the other from impaired steroid-enzyme activity. Neither is contagious.
- HighSpecialist follow-up
Care may involve genetics, cardiology, immunology, endocrinology, or development services according to findings.
- MediumWarning symptoms
Seek urgent care for severe illness, fainting, marked weakness, chest symptoms, or concerning blood-pressure changes.